Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Prospective, Observational study to evaluate the efficacy and safety of Sofosbuvir plus Ribavirin in Korean patients with genotype 2 Hepatitis C Virus Infection

Trial Profile

A Prospective, Observational study to evaluate the efficacy and safety of Sofosbuvir plus Ribavirin in Korean patients with genotype 2 Hepatitis C Virus Infection

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 May 2018

At a glance

  • Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 May 2018 New trial record
    • 14 Apr 2018 Results presented at The International Liver Congress 2018
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top